
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 0.33 | 0.53 | 0.20 |
Shares | 97.58 | 97.58 | 0.00 |
Other | 2.10 | 2.22 | 0.12 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 17.42 | 18.94 |
Price to Book | 4.77 | 4.24 |
Price to Sales | 5.45 | 2.33 |
Price to Cash Flow | 16.76 | 15.92 |
Dividend Yield | 1.14 | 1.17 |
5 Years Earnings Growth | 6.83 | 11.59 |
Number of long holdings: 179
Number of short holdings: 4
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
AbbVie | US00287Y1091 | 12.77 | 190.77 | +0.41% | |
Amgen | US0311621009 | 9.79 | 296.91 | +2.20% | |
Krystal Biotech | US5011471027 | 8.08 | 141.40 | +1.72% | |
Gilead | US3755581036 | 6.87 | 111.63 | -0.09% | |
Alnylam | US02043Q1076 | 4.65 | 327.00 | +1.53% | |
Vertex | US92532F1003 | 3.56 | 455.77 | +0.80% | |
Regeneron Pharma | US75886F1075 | 3.45 | 547.10 | +2.28% | |
Ascendis Pharma AS | US04351P1012 | 2.76 | 172.71 | +0.41% | |
argenx ADR | US04016X1019 | 2.72 | 545.92 | +0.64% | |
UCB | BE0003739530 | 2.12 | 166.70 | -0.09% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Fidelity 500 Index Institutional Pr | 665.84B | 1.06 | 14.40 | 12.85 | ||
Fidelity Contrafund | 153.33B | 4.72 | 21.82 | 15.21 | ||
Fidelity Total Market Index Instl b | 111.51B | 0.53 | 13.74 | 12.15 | ||
Fidelity International Index Inst | 64.89B | 17.65 | 11.69 | 6.14 | ||
Fidelity Blue Chip Growth | 64.78B | -3.61 | 21.81 | 16.87 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review